900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	est un(e) (attribut)	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Phenylephrine hydrochloride 10% conventional release eye drops (product)	Phenylephrine hydrochloride 100 mg/mL eye solution
Phenylephrine hydrochloride 10% single-use eye drops (product)	Phenylephrine hydrochloride 100 mg/mL eye solution
Phenylephrine hydrochloride 2.5% conventional release eye drops	Phenylephrine hydrochloride 25 mg/mL eye solution
Phenylephrine hydrochloride 2.5% single-use eye drops (product)	Phenylephrine hydrochloride 25 mg/mL eye solution
Phenylephrine hydrochloride 2.5% solution (product)	Product containing only phenylephrine (medicinal product)
Phenylpiperazine antidepressant (substance)	Phenylpiperazine derivative (substance)
Phenylpropanolamine hydrochloride adverse reaction	Adverse reaction to phenylpropanolamine
Phenylpropanolamine hydrochloride allergy	Allergy to phenylpropanolamine (finding)
Phenytoin sodium 30mg m/r capsule (product)	Phenytoin only product in oral dose form
Phenytoin sodium 30mg prolonged-release oral capsule	Phenytoin only product in oral dose form
Phialophora richardsiae (organism)	Pleurostomophora richardsiae (organism)
Phocanema decipiens	Pseudoterranova decipiens
Pholcoline (substance)	Pholcodine (substance)
Phosphocol, p-32 15mCi injection suspension 10mL vial (product)	Chromic phosphate (32-P) only product in parenteral dose form
Phospholipase specific extract (product)	Product containing phospholipase (medicinal product)
Phospholipid + protein 35mg/0.65mg suspension (product)	Product containing only calfactant (medicinal product)
Phosphoric diester hydrolase	Phosphoric diester hydrolase
Phosphoric monoester hydrolase	Phosphoric monoester hydrolase
Phosphorus-32(diagnostic) (product)	Product containing phosphorus-32 (medicinal product)
Phosphorus-oxygen lyase	Phosphorus-oxygen lyase
Phosphotransferase	Substance with kinase mechanism of action (substance)
Photoptarmosis	Photoptarmosis
Photorhabdus luminescens subspecies thracensis (organism)	Photorhabdus temperata subspecies thracensis (organism)
Photosensitizing drugs	Drug or medicament (substance)
Phthalic anhydride specific extract (product)	Phthalic anhydride
Phylum acanthocephala	Phylum Acanthocephala (organism)
Phylum microspora	embranchement Microsporidia (organisme)
Physical examination - action	action : examen
Physical medicine iontophoresis	Iontophoresis procedure (regime/therapy)
service de physiatrie	Physical medicine service (qualifier value)
Physical science technician	Physics technician
Physiological jaundice (& [NOS])	Newborn physiological jaundice (disorder)
Physostigmine 0.25% eye drops (product)	Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine 0.5% eye drops (product)	Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine+pilocarpine 0.25%+2% eye drops (product)	Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
Physostigmine+pilocarpine 0.25%+4% eye drops (product)	Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine+pilocarpine 0.5%+4% eye drops (product)	Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)
Pichia ohmeri	Kodamaea ohmeri (organism)
Pick's cell	Niemann-Pick cell (cell)
Picornavirus	Family Picornaviridae (organism)
Pieds gonflés	Swelling of bilateral feet (finding)
Pigeon droppings protein (substance)	Pigeon droppings
Pigmented skin lesion of suspected malignant nature (disorder)	Suspected malignant pigmented skin lesion (situation)
Pilocarpine hydrochloride 10% eye drops (product)	Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug)
Pilocarpine hydrochloride 5.0mg tablet (product)	Product containing precisely pilocarpine hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug)
Pilocarpine nitrate 1% conventional release eye drops	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 1% single-use eye drops (product)	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 2% conventional release eye drops	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 2% single-use eye drops (product)	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% conventional release eye drops	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% single-use eye drops (product)	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% single-use eye drops (product)	Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocytic astrocytoma	Pilocytic astrocytoma
Pilonidal cyst with no abscess	Pilonidal cyst (disorder)
Pioglitazone 15mg + metformin 1g m/r tablet (product)	Metformin and pioglitazone only product in oral dose form
Pioglitazone 15mg + metformin 1g prolonged-release oral tablet	Metformin and pioglitazone only product in oral dose form
Pioglitazone 30mg + metformin 1g m/r tablet (product)	Metformin and pioglitazone only product in oral dose form
Pioglitazone 30mg + metformin 1g prolonged-release oral tablet (product)	Metformin and pioglitazone only product in oral dose form
Piperacillin 3g injection (product)	Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial
Piperacillin 4g infusion set (product)	Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
Piperacillin sodium + tazobactam sodium ns/ns injection (product)	médicament contenant pipéracilline et tazobactam
Piperacillin sodium 3g powder for injection solution vial (product)	Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial
Piperacillin sodium 4g powder for injection solution vial (product)	Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
Piperazine+sennosides 4g/15.3mg/sachet oral powder (product)	Product containing only piperazine and sennoside (medicinal product)
Piperidolate hydrochloride adverse reaction	Adverse reaction to piperidolate (disorder)
Piple cumanesis cumanesis	Aburria cumanensis subspecies cumanensis (organism)
Pirbuterol acetate 0.2mg aerosol (product)	Product containing only pirbuterol (medicinal product)
Piringer's lymphadenitis	Lymphadenitis caused by Toxoplasma gondii (disorder)
Piringer-Kuchinka's syndrome	Lymphadenitis caused by Toxoplasma gondii (disorder)
Piringer-Kuchinka's syndrome (disorder)	Lymphadenitis caused by Toxoplasma gondii (disorder)
Piroxicam 10mg dispersible tablet (product)	Piroxicam 10 mg oral tablet
Piroxicam 20mg conventional release orodispersible tablet	Piroxicam 20 mg oral tablet
Piroxicam 20mg dispersible tablet (product)	Piroxicam 20 mg oral tablet
Piroxicam 20mg melt tablet (product)	Piroxicam 20 mg oral tablet
Pitt Hopkins-like syndrome (disorder)	CNTNAP2-related developmental and epileptic encephalopathy
Pituitary adenoma	Benign pituitary adenoma (morphologic abnormality)
Pituitary hypothyroidism (disorder)	Secondary hypothyroidism
Pituitary interstitial cell stimulating hormone	Pituitary luteinizing hormone
Pityriasis lichenoides chronica	pityriasis lichénoïde chronique (trouble)
Pityriasis lichenoides et varioliformis acuta	pityriasis lichénoïde et varioliforme aigu (trouble)
Pityriasis lichenoides et varioliformis of Mucha-Habermann (disorder)	pityriasis lichénoïde et varioliforme aigu (trouble)
Pityrosporum folliculitis	Malassezia folliculitis (disorder)
Pityrosporum infection of skin	Malassezia infection of skin (disorder)
Pizotifen 250micrograms/5mL elixir (product)	Product containing precisely pizotifen 50 microgram/1 milliliter conventional release oral solution (clinical drug)
Placement	action : insertion
Placenta previa found before labor AND delivery by cesarean section without hemorrhage (disorder)	Placenta previa without hemorrhage - delivered
Planococcus okeanokoites	Planomicrobium okeanokoites
Plant fiber (substance)	Plant fiber
Plasma cell leukemia (morphologic abnormality)	Plasma cell leukemia
Plasma cell myeloma - category (morphologic abnormality)	Plasma cell myeloma
Plasma factor V level	Clotting factor V assay
Plasma factor V level	Clotting factor V assay
Plasma kallikrein	Kallikrein
Plasmacytoma - category (morphologic abnormality)	Plasmacytoma
Plasmin activator	Substance with plasminogen activator mechanism of action (substance)
Plasminogen activator	Substance with plasminogen activator mechanism of action (substance)
Plasminogen inactivator (substance)	Plasminogen activator inhibitor
Plaster (physical object)	Adhesive plaster
Plasters	Adhesive plaster
Platelet precursor	Megakaryocytic cell (cell)
Platelet satellite (cell structure)	Platelet satellite

Start Previous Page 74 of 132 Next End

Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)